Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Yoshimura

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|February 21, 2025
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort studyToshiaki Tsurui, Kazuyuki Hamada, Emiko Mura, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2019
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancersTomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, et al.
Cancer Science|February 9, 2018
Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cellsMitsuo Nishiyama, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
European Journal of Pharmacology|May 4, 2025
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in miceYuki Maruyama, Masahiro Hosonuma, Hitoshi Toyoda, et al.
Pancreas|April 9, 2021
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune SurveillanceYasuhiro Fujiwara, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1<sup>+</sup> CD14<sup>+</sup> monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.
Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.
Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.
The Journal of Clinical Investigation|March 25, 2006
Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitisSudarshan Anand, Pu Wang, Kiyoshi Yoshimura, et al.
BMC Cancer|March 12, 2022
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cellsRyouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|February 21, 2025
Evaluation of patient immunocompetence for immune checkpoint inhibitor therapy using the psoas muscle index: a retrospective cohort studyToshiaki Tsurui, Kazuyuki Hamada, Emiko Mura, et al.
Cancer Immunology, Immunotherapy : CII|November 27, 2019
Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancersTomohiro Kikuchi, Kosaku Mimura, Mai Ashizawa, et al.
Cancer Science|February 9, 2018
Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cellsMitsuo Nishiyama, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
European Journal of Pharmacology|May 4, 2025
Combination therapy with cetirizine and anti-PD-1 antibody suppresses colitis-induced colon tumor formation in miceYuki Maruyama, Masahiro Hosonuma, Hitoshi Toyoda, et al.
Pancreas|April 9, 2021
Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune SurveillanceYasuhiro Fujiwara, Ryouichi Tsunedomi, Kiyoshi Yoshimura, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2020
A high number of PD-L1<sup>+</sup> CD14<sup>+</sup> monocytes in peripheral blood is correlated with shorter survival in patients receiving immune checkpoint inhibitorsKiyohiro Ando, Kazuyuki Hamada, Midori Shida, et al.
Cancer Research|May 14, 2009
Cyclophosphamide augments antitumor immunity: studies in an autochthonous prostate cancer modelSatoshi Wada, Kiyoshi Yoshimura, Edward L Hipkiss, et al.
Journal of Translational Medicine|April 6, 2013
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancerSatoshi Wada, Christopher M Jackson, Kiyoshi Yoshimura, et al.
The Journal of Clinical Investigation|March 25, 2006
Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitisSudarshan Anand, Pu Wang, Kiyoshi Yoshimura, et al.
BMC Cancer|March 12, 2022
Elevated expression of RAB3B plays important roles in chemoresistance and metastatic potential of hepatoma cellsRyouichi Tsunedomi, Kiyoshi Yoshimura, Yuta Kimura, et al.
Pageof 11